A study on the effect of continuous intake of test foods on immune function. -a randomized, placebo-controlled, double-blind, parallel-group comparison trial
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000046189
- Lead Sponsor
- IMEQRD Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Not provided
1.Individuals who have mouth dryness, or hypersalivation. 2.Individuals who are currently undergoing treatment for any disease with medical drugs or traditional Chinese medicines. 3.Individuals who are managed by medical doctors for diet/exercise therapy. 4.Individuals who have severe diseases or a history of severe diseases. 5.Individuals who have allergic dermatitis, allergic rhinitis, bronchial asthma, or chronic bronchitis. 6.Individuals who have been taking yogurts or beverages, which include Lactic acid bacteria and/or Bifidobacterium. However, individuals who can discontinue taking these foods during the trial will be allowed. 7.Individuals who have currently been taking commercially available drugs, quasi-drug products, and foods or supplements with functional claims. However, who can discontinue taking these materials during the trial will be allowed. 8.Individuals who have a drug/food allergy. 9.Individuals who work in shift, night shift. 10.Individuals who are planning extremely change their lifestyle during the trial. 11.Individuals who drink more than 60 g alcohol/day. 12.Individuals who have been vaccinated to protect against infectious disease one month before this study. Also, planning vaccination during the trial period. 13.Individuals who are planning travel to foreign countries during the trial. 14.Individuals who are pregnant or breastfeeding. Also, planning to pregnant during the trial period. 15.Individuals who joined other clinical trials from 1 month before this trial, or those who have currently been joined or planning to join other clinical trials. 16.Individuals who donated blood more than 200 mL within one month, or more than 400 mL within three months before the screening period. 17.Individuals who cannot discontinue taking alcoholic drinks two days before the date of visit. 18.Individuals who are unsuitable for this trial, that judged by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method